name nAnno nOverlap fc zscore pvalue adjp or CIl CIu
R-HSA-112316 Neuronal System 356 15 3.98 5.92 4.7e-06 0.00042 4.62 2.46 8.14
R-HSA-5576892 Phase 0 - rapid depolarisation 46 5 10.3 6.52 0.00012 0.0053 11.9 3.6 31
R-HSA-977443 GABA receptor activation 55 5 8.59 5.84 0.00028 0.0062 9.75 2.97 25
R-HSA-112314 Neurotransmitter receptors and postsynaptic signal transmission 154 8 4.91 5.05 0.00022 0.0062 5.46 2.25 11.5
R-HSA-8939243 RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known 38 4 9.94 5.71 0.00066 0.0073 11.4 2.88 32.8
R-HSA-977444 GABA B receptor activation 39 4 9.69 5.62 0.00073 0.0073 11 2.8 31.7
R-HSA-991365 Activation of GABAB receptors 39 4 9.69 5.62 0.00073 0.0073 11 2.8 31.7
R-HSA-5576891 Cardiac conduction 139 7 4.76 4.61 0.00066 0.0073 5.23 2.01 11.5
R-HSA-112315 Transmission across Chemical Synapses 224 9 3.8 4.38 6e-04 0.0073 4.18 1.83 8.42
R-HSA-6794362 Protein-protein interactions at synapses 70 5 6.75 4.99 0.00085 0.0076 7.49 2.31 19
R-HSA-388844 Receptor-type tyrosine-protein phosphatases 20 3 14.2 6.1 0.0012 0.0094 16.9 3.13 59.7
R-HSA-1296041 Activation of G protein gated Potassium channels 25 3 11.3 5.35 0.0022 0.014 13.1 2.47 44.5
R-HSA-1296059 G protein gated Potassium channels 25 3 11.3 5.35 0.0022 0.014 13.1 2.47 44.5
R-HSA-997272 Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits 25 3 11.3 5.35 0.0022 0.014 13.1 2.47 44.5
R-HSA-1296065 Inwardly rectifying K+ channels 31 3 9.14 4.7 0.0042 0.025 10.3 1.97 34.1
R-HSA-397014 Muscle contraction 201 7 3.29 3.39 0.0054 0.03 3.54 1.37 7.71
R-HSA-6802957 Oncogenic MAPK signaling 76 4 4.97 3.59 0.0085 0.045 5.36 1.39 14.7
